000 | 01987nam a22003495i 4500 | ||
---|---|---|---|
001 | 277010 | ||
003 | MX-SnUAN | ||
005 | 20160429153800.0 | ||
007 | cr nn 008mamaa | ||
008 | 160108s2015 xxk| s |||| 0|eng d | ||
020 |
_a9781447149200 _9978-1-4471-4920-0 |
||
035 | _avtls000414501 | ||
039 | 9 |
_y201601081052 _zstaff |
|
050 | 4 | _aR1 | |
245 | 1 | 0 |
_aTranslational research methods for diabetes, obesity and cardiometabolic drug development : _ba focus on early phase clinical studies / _cedited by Andrew J. Krentz, Lutz Heinemann, Marcus Hompesch. |
264 | 1 |
_aLondon : _bSpringer London : _bSpringer, _c2015. |
|
300 |
_axii, 312 páginas : _b76 ilustraciones, 39 ilustraciones en color. |
||
336 |
_atexto _btxt _2rdacontent |
||
337 |
_acomputadora _bc _2rdamedia |
||
338 |
_arecurso en línea _bcr _2rdacarrier |
||
347 |
_aarchivo de texto _bPDF _2rda |
||
500 | _aSpringer eBooks | ||
505 | 0 | _a1. Review of physiology/pathophysiology -- 2. Methods for assessing insulin action in humans -- 3. Assessment of insulin secretion -- 4. Measurement of ectopic fat in liver and muscle using magnetic resonance spectroscopy -- 5. Isotopic tracers for the measurement of metabolic flux -- 6. Measuring food intake in clinical drug development -- 7. Measurement of energy expenditure -- 8. Assessment of body composition -- 9. Assessment of cardiovascular safety of new diabetes drugs. | |
590 | _aPara consulta fuera de la UANL se requiere clave de acceso remoto. | ||
700 | 1 |
_aKrentz, Andrew J, _eeditor. _9299377 |
|
700 | 1 |
_aHeinemann, Lutz, _eeditor. _9299378 |
|
700 | 1 |
_aHompesch, Marcus, _eeditor. _9299379 |
|
710 | 2 |
_aSpringerLink (Servicio en línea) _9299170 |
|
776 | 0 | 8 |
_iEdición impresa: _z9781447149194 |
856 | 4 | 0 |
_uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-1-4471-4920-0 _zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL) |
942 | _c14 | ||
999 |
_c277010 _d277010 |